• Synexus sees Ukraine as a "key market" for growth going forward
  • Synexus continues to expand its 4 centres in Poland. Gdynia is moving to much larger premises. Wroclaw is increasing by several hundred metres square
  • During the first quarter of 2010, Synexus has seen growth in Germany reach thirty per cent as international sponsors take advantage of the additional patient reach the company can now offer following its acquisition of eight Clinpharm sites
  • Synexus randomised 2,700 patients in 10 months for major osteoporosis study
  • Dr Sanet Aspinall, Managing Director of Synexus South Africa, spoke about the great strengths that Synexus South Africa has in running clinical trials - three modern clinical trial sites, well trained medical staff and access to a wide variety of populations - at the 1st Annual Patient Recruitment Conference in Clinical Trials in SA
  • Synexus bucks the UK trend and continues to increase the numbers of patients recruited to UK-based clinical trials
  • Synexus recruited more than 2,000 children to ground-breaking paediatric vaccine trial
  • Michael Fort, Chief Executive of Synexus has been named Ernst & Young Turnaround Entrepreneur of the Year in the 2010 Awards
  • Synexus has recently invested in Doppler Ultrasound equipment for each of its seven UK-based Dedicated Research Centres. After training for all Synexus’ doctors, the facilities are now being used as part of the drive to recruit patients to a new diabetes study

Who we are

Synexus, headquartered in Manchester, continues to pioneer important developments in the clinical trials industry. Through a global network of 26 Dedicated Research Centres (DRCs) in nine countries Synexus provides first class clinical trials data to its clients from pharma, biotechs and CROs.

More about Synexus

What We Do

Synexus recruits patients and runs clinical trials at its own Dedicated Research Centres staffed by full time GCP investigators who work solely on clinical trials. The Synexus model has been designed to:

  • Speed up clinical trials
  • Reduce costs
  • Provide access to millions of patients worldwide

Who We Work For

You will need to download the flash player to view this content.

Synexus’ client base comprises some of the world's leading pharma, biotechs and CROs.   

More about our clients

Our Expertise

Synexus' expertise across a growing number of therapy areas is ensuring clients reach the agreed number of patients, on time and at a competitive cost. 

More about therapy areas

Latest News

Follow Synexus on Twitter

Synexus Newsletter

Synexus Videos

View all videos

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY